Title : Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quino linone monomethanesulfonate) - Tottori_2002_J.Pharmacol.Exp.Ther_301_249 |
Author(s) : Tottori K , Nakai M , Uwahodo Y , Miwa T , Yamada S , Oshiro Y , Kikuchi T , Altar CA |
Ref : Journal of Pharmacology & Experimental Therapeutics , 301 :249 , 2002 |
Abstract : Tottori_2002_J.Pharmacol.Exp.Ther_301_249 |
ESTHER : Tottori_2002_J.Pharmacol.Exp.Ther_301_249 |
PubMedSearch : Tottori_2002_J.Pharmacol.Exp.Ther_301_249 |
PubMedID: 11907181 |
Tottori K, Nakai M, Uwahodo Y, Miwa T, Yamada S, Oshiro Y, Kikuchi T, Altar CA (2002)
Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quino linone monomethanesulfonate)
Journal of Pharmacology & Experimental Therapeutics
301 :249
Tottori K, Nakai M, Uwahodo Y, Miwa T, Yamada S, Oshiro Y, Kikuchi T, Altar CA (2002)
Journal of Pharmacology & Experimental Therapeutics
301 :249